Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureTrine Lembrecht Jørgensen, Jørn Herrstedt, S. Friis, Jesper Hallas
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
Comorbidity and polypharmacy in elderly cancer patients: The significance on treatment outcome and tolerance
2010 · 38 citations
Factors leading oncologists to refer elderly cancer patients for geriatric assessment
2011 · 25 citations
Cancer in nonagenarians: profile, treatments and outcomes
2010 · 12 citations
No local citing links have been materialized yet.
Department of economic and social affairs. Population division
2001
Interaction between comorbidity and cancer
10.1177/107327480701400103 · 2007
Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting
10.1592/phco.2005.25.11.1636 · 2005
Methods for estimating the occurrence of polypharmacy by means of a prescription database
10.1007/s002280050329 · 1997
Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems
10.1111/j.1365-2125.2006.02744.x · 2007
Polypharmacy: correlations with sex, age and drug regimen. A prescription database study
10.1007/s002280050445 · 1998
Potential for drug interactions in hospitalized cancer patients
10.1007/s00280-004-0998-4 · 2005
Polypharmacy in the older patient with cancer
10.1177/107327489700400505 · 1997
Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit
10.1016/j.amjopharm.2009.05.002 · 2009
ror
Confidence 99%
ror
Confidence 99%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation
10.1177/1078155208090624 · 2008
Medication problems in older, newly diagnosed cancer patients in canada: how common are they? A prospective pilot study
10.2165/00002512-200926060-00008 · 2009
Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management
10.1111/j.1365-2710.2007.00815.x · 2007
Potential drug interactions in elderly cancer patients
2010
The Danish prescription registries
1997
The Danish National Prescription Registry
10.1177/1403494810394717 · 2011
The Danish civil registration system
10.1177/1403494810387965 · 2011
The Danish Cancer Registry — history, content, quality and use
1997
The Danish Cancer Registry
10.1177/1403494810393562 · 2011
Unresolved referenced work
2003
Risk set sampling in epidemiologic cohort studies
10.1214/ss/1032209663 · 1996
Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers
10.1038/sj.bjc.6605398 · 2009
Cancer in nonagenarians: profile, treatments and outcomes
10.1016/j.jgo.2010.03.003 · 2010
Factors leading oncologists to refer elderly cancer patients for geriatric assessment
10.1016/j.jgo.2011.03.001 · 2011
Aging biology and geriatric clinical pharmacology
10.1124/pr.56.2.4 · 2004
Comorbidity and polypharmacy in elderly cancer patients: the significance on treatment outcome and tolerance
10.1016/j.jgo.2010.06.003 · 2009
Danish drug consumption trends
2009
Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological model
10.1111/j.1365-2125.2008.03282.x · 2008
Conducting pharmacoepidemiologic research in Denmark
10.1002/pds.638 · 2001
NORDCAN: cancer incidence, mortality, prevalence and prediction in the nordic countries
2010
Unresolved referenced work
Kept as external metadata until matched
The consumption of drugs by 75-year-old individuals living in their own homes
10.1007/s002280000157 · 2000
Herb and supplement use in the US adult population
10.1016/j.clinthera.2005.11.004 · 2005
Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs
10.1089/107555302760253676 · 2002
A systematic review of the associations between dose regimens and medication compliance
10.1016/s0149-2918(01)80109-0 · 2001
No additional external references are available.